Please try another search
R J Biotech Limited reported earnings results for the full year ended March 31, 2022. For the full year, the company reported sales was INR 138.97 million compared to INR 157.96 million a year ago. Revenue was INR 145.71 million compared to INR 157.96 million a year ago. Net loss was INR 91.58 million compared to INR 156.82 million a year ago. Basic loss per share from continuing operations was INR 9.67 compared to INR 16.56 a year ago.
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Revenue | 9.76 | 116.74 | ||
Gross Profit | 2.51 | 65.2 | ||
Operating Income | 3 | -3.04 | ||
Net Income | -45.6 | -0.38 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Total Assets | 19.19 | 19.19 | 20.41 | 58.61 |
Total Liabilities | 522.59 | 522.59 | 432.62 | 470.43 |
Total Equity | -503.4 | -503.4 | -412.2 | -411.82 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Mar 31, 2021 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 6 Months | 0 Months |
Cash From Operating Activities | -22.55 | -2.06 | ||
Cash From Investing Activities | 0.614 | -1.23 | ||
Cash From Financing Activities | 21.94 | 2.89 | ||
Net Change in Cash | -0.001 | -0.39 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review